About
Contract Manufacturing, Formulation Development, Generics
Areas of Focus
Categories
Contract ManufacturingContract ManufacturingContract ManufacturingContract ResearchGeneric DrugContract ManufacturingIndia
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
2
As Collaborator
1
Total Enrollment
1,001
By Phase
PHASE3: 1PHASE1: 2
By Status
COMPLETED: 2RECRUITING: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT03671044Collaborator
A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients
PHASE3Recruiting
657 participants
Started: Jul 10, 2018 · Completed: Dec 31, 2025
NCT04015232Lead Sponsor
Comparative Immunogenicity Study of Multiple Doses of Proposed Pegfilgrastim Biosimilar, INTP5 of Intas Pharmaceuticals Ltd., India Against Neulasta of Amgen Inc., USA in Healthy, Adult Human Subjects.
PHASE1Completed
200 participants
Started: Feb 26, 2018 · Completed: Jun 5, 2018
NCT04014062Lead Sponsor
Comparative, Pharmacokinetic and Pharmacodynamic Study of Subcutaneous Injections of INTP5 of Intas Pharmaceuticals Ltd., India Against Neulasta of Amgen Inc., USA in Healthy, Adult Human Subjects.
PHASE1Completed
144 participants
Started: Feb 12, 2018 · Completed: May 1, 2018
Locations (1)
Headquarters
Ahmedabad, India
Map
Loading map...